# The Goldilocks paradox: when partial oncoprotein inhibition fuels metastasis in Ewing sarcoma

**Authors:** Marie Castets, Adrien Bertrand-Chapel, Jean-Yves Blay

PMC · DOI: 10.1038/s44321-025-00365-6 · EMBO Molecular Medicine · 2026-01-03

## TL;DR

This paper shows that partial inhibition of a cancer-causing protein in Ewing sarcoma can actually make the cancer more likely to spread.

## Contribution

The study reveals a paradox where incomplete oncoprotein inhibition promotes metastasis in Ewing sarcoma.

## Key findings

- Incomplete EWS::FLI1 inhibition promotes metastatic behavior in Ewing sarcoma.
- This finding has critical implications for developing therapeutic strategies in pediatric oncology.

## Abstract

Targeting oncogenic fusion proteins remains a major challenge in pediatric oncology. In this issue of EMBO Molecular Medicine, Suresh et al (2025) demonstrate that incomplete inhibition of EWS::FLI1 in Ewing sarcoma paradoxically promotes metastatic behavior, revealing critical implications for therapeutic strategies.

JY Blay & colleagues discuss the study by Suresh et al, in this issue of EMBO Mol Med, that shows that incomplete inhibition of EWS::FLI1 in Ewing sarcoma paradoxically promotes metastatic behavior.

## Linked entities

- **Proteins:** EWSR1 (EWS RNA binding protein 1)
- **Diseases:** Ewing sarcoma (MONDO:0012817)

## Full-text entities

- **Diseases:** metastasis (MESH:D009362), Ewing sarcoma (MESH:D012512)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12904855/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12904855/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12904855/full.md

---
Source: https://tomesphere.com/paper/PMC12904855